Kura Oncology(KURA)
SAN DIEGO, CABiotechnology
Focus: Kura Oncology is a public San Diego-based biotech focused on small-molecule oncology therapeutics, currently in clinical-stage development with no marketed products.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
10+1 this month
Stable — net +1 jobs in 30d
7 added, 6 removed. Backfill posture.
Should You Work at Kura Oncology?
AI assessmentKura is a high-risk, high-reward mid-cap biotech best suited for scientists and operators comfortable with clinical-stage volatility and hungry to build a commercial organization around a leukemia/lymphoma franchise.
Why Work Here
- Leading pipeline depth with 20 active trials across 4 development phases, including 1 Phase 3 program (Ziftomenib in AML) that represents a near-term catalyst opportunity.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT04809233Expanded Access to Tipifarnib
N/AHelp build intelligence for Kura Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.